| Dr Lamberto Opulencia Flores, MD | |
|
305 W 15th St, Ste 104, Liberal, KS 67901-2455 | |
| (620) 624-9637 | |
| (620) 624-2218 |
| Full Name | Dr Lamberto Opulencia Flores |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 305 W 15th St, Liberal, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891743845 | NPI | - | NPPES |
| 200644000J | Medicaid | KS | |
| 200313900A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 04-34311 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Medical Center | 7517941651 | 25 |
News Archive
MILabs installs its industry-leading microCT system at The Center of Excellence for Translational Imaging at National Yang-Ming University in Taipei of East Asia.
DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
New research suggests that popular statin drugs may not only lower levels of "bad" LDL cholesterol but also raise levels of "good" HDL cholesterol.
› Verified 5 days ago
| Entity Name | Southwest Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144493040 PECOS PAC ID: 7517941651 Enrollment ID: O20040805001105 |
News Archive
MILabs installs its industry-leading microCT system at The Center of Excellence for Translational Imaging at National Yang-Ming University in Taipei of East Asia.
DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
New research suggests that popular statin drugs may not only lower levels of "bad" LDL cholesterol but also raise levels of "good" HDL cholesterol.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lamberto Opulencia Flores, MD Po Box 1215, Attn Clinic Billing Office, Liberal, KS 67905-1215 Ph: (620) 629-6638 | Dr Lamberto Opulencia Flores, MD 305 W 15th St, Ste 104, Liberal, KS 67901-2455 Ph: (620) 624-9637 |
News Archive
MILabs installs its industry-leading microCT system at The Center of Excellence for Translational Imaging at National Yang-Ming University in Taipei of East Asia.
DanDrit Biotech A/S ("DanDrit Denmark"), the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST – National Institute for Cancer Research known as the San Martino Hospital of Genoa.
InterMune, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review and granted Priority Review designation for the company's New Drug Application (NDA) for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis (IPF).
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) will be presented at the Ninth International Kidney Cancer Symposium (IKCS) in Chicago, Illinois, October 1-2, 2010.
New research suggests that popular statin drugs may not only lower levels of "bad" LDL cholesterol but also raise levels of "good" HDL cholesterol.
› Verified 5 days ago
Melia Stoll, ARNP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 222 W 15th St, Liberal, KS 67901 Phone: 620-624-3811 Fax: 620-624-3186 | |
William (bill) Joseph Michael Settle, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2132 N Kansas Avenue, Suite C, Liberal, KS 67901 Phone: 620-624-1530 Fax: 620-624-3210 | |
Dennis Knudsen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 222 W 15th St, Liberal, KS 67901 Phone: 620-624-3811 Fax: 620-624-3186 |